Home LiteratureArticle Details
PMID: 9237683 Published · ppublish English Journal Article

RNA polymerase I from S. cerevisiae depends on an additional factor to release terminated transcripts from the template.

FEBS letters ·Vol. 410 ·No. 2-3 ·1997-06-30 ·Pages 461-6

Tschochne H, Milkereit P

Abstract

Terminated transcripts were generated at the ends of linearized DNA templates and at DNA-bound lac repressor by in vitro transcription with highly enriched or purified yeast RNA polymerase I (pol I). The release of the synthesized transcripts from the DNA was analyzed using immobilized DNA as template for the transcription reaction. An additional activity distinguishable from pol I was necessary to remove the terminated RNA from the template. Efficiency of transcript release could be improved if a thymidine-rich DNA fragment was located upstream of the transcriptional arrest caused by the DNA-bound lac repressor. The release activity interacted with different forms of polymerases, pol I able to initiate on the ribosomal gene promoter and pol I only active in non-specific transcription.

MeSH Terms
Binding Sites DNA, Fungal/metabolism Promoter Regions, Genetic RNA Polymerase I/metabolism RNA, Fungal/metabolism RNA, Messenger/metabolism Saccharomyces cerevisiae/enzymology Templates, Genetic Transcription, Genetic
Chemicals
DNA, Fungal RNA, Fungal RNA, Messenger RNA Polymerase I
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Tschochne H
BZH, Biochemie-Zentrum Heidelberg, Germany. IM4@ix.urz.uni-heidelberg.de
Milkereit P
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1997-06-30
Pages
461-6
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com